Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a buddy and a phone app help people with HIV stay healthy?

NCT ID NCT05427318

Disease control Sponsor: San Diego State University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study tested a program that pairs peer support with a mobile app to help Hispanic and Black people with HIV stay on treatment. 309 participants were randomly assigned to the program or standard care. The goal was to see if the program helps more people achieve an undetectable viral load and stay in care.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
peer navigation plus mobile app (Camino)
What this could lead to
If it works, this approach could offer a practical way to help people with HIV stick to their medication and keep the virus under control.
What could go wrong
This is a completed trial, but the intervention is behavioral, not a drug, so results may vary by setting. It also requires internet access and may not work for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

309 people

The number who actually took part.

Started

Nov 2021

Finished

Jul 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * ≥18 years old * Can read and speak English or Spanish * Self-reported diagnosis of HIV by a physician or healthcare provider * Currently prescribed HIV medication * Having access to an internet browser on a home computer, tablet, or smart phone * Does not plan to move out of the San Diego area in the next 12 months * Meets one or more of the following medical chart verified or self-reported criteria * One or more detectable viral load test result (\>200 copies m/L) in the past 12-months while on antiretroviral therapy for at least 3 months * Having missed 1 or more scheduled HIV care appointments in the last 12 months * Last HIV care visit was more than 6 months ago * Self-reporting less than 90% antiretroviral therapy adherence in the last 4 weeks using the Wilson-3 scale * Report stimulant or opioid use (non-prescription) in the past 6 months Exclusion Criteria: * \<18 years old * Currently enrolled in any program, intervention, or research study designed to improve antiretroviral therapy adherence or engagement in HIV care (e.g., LinkPositively) * Members of one of the community advisory boards providing advisement on the study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Human immunodeficiency virus are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

AIDS HIV infectious disease substance-related disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Human immunodeficiency virus

Contacts and locations

Locations

  • San Ysidro Health

    San Ysidro, California, 91910, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.